| Indiana
Trial: Summary |
|
|
|
|
|
|
|
|
|
|
| l | Best
HSC gene transfer and |
||||||||
| expression
to date |
|||||||||
| l | MDR-transduced
cells selected by |
||||||||
| chemotherapy |
|||||||||
| l | Retronectin
effect positive |
||||||||
| l | TPO,
SCF, G-CSF growth factors best |
||||||||
| l | Lack
of competition of fresh and |
||||||||
| transduced
cells critical |
|||||||||